Biotech Values

[jbog]

After the numbers released by Gilead today it looks like V-Pak ran at less than 4% in the U.S. and a tad less than 8% in the international HCV markets.

The cafepharma clowns basically say they have no one to call on because the Doc's don't have the final decision in the U.S. They are saying that they are giving doc's free script coupons now.

We'll see how this plays out.